Kevin st. Pierre

Kevin St. Pierre has extensive experience in incentive compensation and sales strategy within the pharmaceutical industry, with roles at notable companies such as Eisai US, Teva Pharmaceuticals, Bayer, Schering-Plough, and Wyeth. Currently serving as Director of Incentive Compensation and Fleet at Eisai US, Kevin oversees the design and implementation of oncology sales incentive programs. At Teva Pharmaceuticals, Kevin managed a $25M incentive strategy budget and previously held positions at Bayer, where responsibilities included leading teams for incentive strategy across multiple healthcare franchises. Kevin began their career as a Quality Assurance Engineer at Schering-Plough and holds a Bachelor of Science in Biological/Biosystems Engineering from Virginia Tech and an MBA in Finance from Fairleigh Dickinson University.